FDA Inspection 1027851 — Aykut Bayrak, MD A Professional Corporation
The FDA completed an inspection of Aykut Bayrak, MD A Professional Corporation on September 13, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Los Angeles, CA (United States)